LRP5L
Basic information
Region (hg38): 22:25351612-25405274
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRP5L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 0 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRP5L | protein_coding | protein_coding | ENST00000402859 | 4 | 53960 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.32e-11 | 0.0168 | 125468 | 2 | 257 | 125727 | 0.00103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.668 | 187 | 163 | 1.15 | 0.0000105 | 1652 |
Missense in Polyphen | 64 | 55.102 | 1.1615 | 565 | ||
Synonymous | -1.73 | 89 | 70.6 | 1.26 | 0.00000521 | 495 |
Loss of Function | -0.851 | 14 | 11.0 | 1.28 | 5.59e-7 | 105 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0129 | 0.0128 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000202 | 0.000202 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.106
- rvis_EVS
- 0.76
- rvis_percentile_EVS
- 86.8
Haploinsufficiency Scores
- pHI
- 0.0920
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.120
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- gastrulation with mouth forming second;osteoblast development;anterior/posterior pattern specification;cholesterol homeostasis;positive regulation of transcription by RNA polymerase II;bone remodeling;bone marrow development;canonical Wnt signaling pathway;bone morphogenesis;branching involved in mammary gland duct morphogenesis;adipose tissue development;regulation of insulin secretion involved in cellular response to glucose stimulus;retinal blood vessel morphogenesis
- Cellular component
- plasma membrane;receptor complex
- Molecular function
- Wnt-protein binding;Wnt-activated receptor activity